µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© vJ>A
>RCB
-h*Yd)
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© k(o[T),_%0
1¡¢Co-stimulators (or co-stimulating molecules) lDV8<
2¡¢NK-kB ,Ihuo5>/z
3¡¢Immunoglobulin superfamily *wP8)yv7
4¡¢antigen-presenting cell (APC) V4qHaG
5¡¢death domain I*@\pc}
6¡¢CCR and CXCR 'T7JXV5
7¡¢Lectin (or mitogen) MLY19 ;e
8¡¢Clusters of differentiation, CD) rMSB|*_
9¡¢B7 family [e3|yE6
10¡¢Cytotoxic T lymphocyte, CTL) %cO;{og M
11¡¢IL-15 and IL-15 receptor (IL-15R) !$AVlMnJ
12¡¢MHC restriction '0X!_w6W
13¡¢Affinity-chromatography n=r}jRH1
14¡¢Cyctosprin A, CsA MTb}um.($
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) f1=BBQY
>
dJ?VN!B0
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© W)^:*z
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 p]`pUw{
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ T =3te|fv
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 BArsj
KU-z;}9s
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© uByF*}d1
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ N$pwTyk
ѪҺ²¡Ñ§×¨Òµ£º ,p1 (0i
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿